Annual Cash & Cash Equivalents
$826.80 K
-$3.22 M-79.56%
31 March 2024
Summary:
OKYO Pharma Limited annual cash & cash equivalents is currently $826.80 thousand, with the most recent change of -$3.22 million (-79.56%) on 31 March 2024. During the last 3 years, it has fallen by -$6.06 million (-88.00%). OKYO annual cash & cash equivalents is now -96.90% below its all-time high of $26.64 million, reached on 31 March 2010.OKYO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.05 M
+$3.34 M+471.71%
31 March 2023
Summary:
OKYO Pharma Limited quarterly cash and cash equivalents is currently $4.05 million, with the most recent change of +$3.34 million (+471.71%) on 31 March 2023. OKYO quarterly cash and cash equivalents is now -84.81% below its all-time high of $26.64 million, reached on 31 March 2010.OKYO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OKYO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.6% | - |
| 3 y3 years | -88.0% | -21.7% |
| 5 y5 years | +31.7% | +5919.9% |
OKYO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.0% | at low | -21.7% | +471.7% |
| 5 y | 5 years | -88.0% | +251.8% | -45.4% | +5919.9% |
| alltime | all time | -96.9% | +251.8% | -84.8% | +5919.9% |
OKYO Pharma Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $826.80 K(-79.6%) | - |
| Mar 2023 | $4.05 M(+49.8%) | $4.05 M(+471.7%) |
| Sept 2022 | - | $707.60 K(-73.8%) |
| Mar 2022 | $2.70 M(-60.8%) | $2.70 M(-47.8%) |
| Sept 2021 | - | $5.17 M(-25.0%) |
| Mar 2021 | $6.89 M(+2831.6%) | $6.89 M(-7.0%) |
| Sept 2020 | - | $7.41 M(+3053.9%) |
| Mar 2020 | $235.00 K(-62.6%) | $235.00 K(+249.7%) |
| Sept 2019 | - | $67.20 K(-89.3%) |
| Mar 2019 | $627.60 K(-77.7%) | $627.60 K(-61.3%) |
| Sept 2018 | - | $1.62 M(-42.4%) |
| Mar 2018 | $2.81 M(-24.9%) | $2.81 M(-21.2%) |
| Sept 2017 | - | $3.57 M(-4.7%) |
| Mar 2017 | $3.75 M(-26.9%) | $3.75 M(-16.5%) |
| Sept 2016 | - | $4.49 M(-12.5%) |
| Mar 2016 | $5.13 M(-20.7%) | $5.13 M(-14.1%) |
| Sept 2015 | - | $5.97 M(-7.6%) |
| Mar 2015 | $6.47 M(-45.3%) | $6.47 M(-25.6%) |
| Sept 2014 | - | $8.68 M(+7210.4%) |
| Aug 2014 | - | $118.80 K(-99.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | $11.82 M(-17.5%) | $11.82 M(+9568.4%) |
| Feb 2014 | - | $122.30 K(-11.8%) |
| Nov 2013 | - | $138.70 K(-97.6%) |
| Sept 2013 | - | $5.68 M(+3894.1%) |
| Aug 2013 | - | $142.10 K(-11.5%) |
| May 2013 | - | $160.50 K(-98.9%) |
| Mar 2013 | $14.34 M(-15.8%) | $14.34 M(+8595.6%) |
| Feb 2013 | - | $164.90 K(-6.5%) |
| Nov 2012 | - | $176.30 K(-99.2%) |
| Sept 2012 | - | $20.88 M(>+9900.0%) |
| Aug 2012 | - | $190.20 K(+7.4%) |
| May 2012 | - | $177.10 K(-99.0%) |
| Mar 2012 | $17.03 M(+6.0%) | $17.03 M(+7779.1%) |
| Feb 2012 | - | $216.20 K(+13.8%) |
| Nov 2011 | - | $190.00 K(-98.8%) |
| Mar 2011 | $16.07 M(-39.7%) | $16.07 M(+1.8%) |
| Sept 2010 | - | $15.78 M(-40.8%) |
| Mar 2010 | $26.64 M(+394.8%) | $26.64 M |
| Mar 2009 | $5.38 M(-70.0%) | - |
| Mar 2008 | $17.97 M | - |
FAQ
- What is OKYO Pharma Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for OKYO Pharma Limited?
- What is OKYO Pharma Limited annual cash & cash equivalents year-on-year change?
- What is OKYO Pharma Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for OKYO Pharma Limited?
What is OKYO Pharma Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of OKYO is $826.80 K
What is the all time high annual cash & cash equivalents for OKYO Pharma Limited?
OKYO Pharma Limited all-time high annual cash & cash equivalents is $26.64 M
What is OKYO Pharma Limited annual cash & cash equivalents year-on-year change?
Over the past year, OKYO annual cash & cash equivalents has changed by -$3.22 M (-79.56%)
What is OKYO Pharma Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OKYO is $4.05 M
What is the all time high quarterly cash and cash equivalents for OKYO Pharma Limited?
OKYO Pharma Limited all-time high quarterly cash and cash equivalents is $26.64 M